1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Limited Competition for the Adolescent Brain Cognitive Development -Extended (ABCD-E) Study-Research Project Sites (U01 Clinical Trial Not Allowed) is sponsored by National Institutes of Health (NIH) / National Institute on Drug Abuse (NIDA). Supports longitudinal research tracking environmental influences—including video games, social media, and digital technology use—and their interaction with adolescent brain development and behavior.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the funder's website rather than a specific solicitation. Confirm program details with the funder.
NIH Websites Are Changing NIH Websites Are Changing Get the Latest Updates and FAQs . Per Executive Order 14434 , federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.
As of October 2025, the NIDA Funding App has been retired. The NIH announcement stating this change can be read here: NOT-OD-25-143 . NIDA Funding Strategy – A review of NIDA’s strategy for funding, based on programmatic priorities.
Notice of Special Interest (NOSI) - Formerly known as Drug Abuse Topics of Special/Continuing Interest (DAT) NIDA Challenges Program – Crowd-sourced opportunities for providing solutions for particular goals. Helping to End Addiction Long-term (HEAL) Initiative – Congressional initiative to address the opioid overdose crisis. NIDA International Program – International research collaboration opportunities on drug abuse and addiction.
See NIDA’s Resources for Grants & Contracts to learn more about applying for a grant and the pre-approval and approval process. Administrative Supplements for Grants & Cooperative Agreements Administrative Supplements for Grants & Cooperative Agreements – Additional funding to an active NIDA grant or cooperative agreement.
Supplemental Information for NOFOs Supplemental Information for NOT-DA-22-064: Notice of Intent to Publish a Funding Opportunity Announcement for NIH Brain Development Cohorts Biospecimen Access FAQs for Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders - RFA-DA-24-007.
FAQs for Registry of Medical Cannabis Use and Health Outcomes: RFA-DA-23-011 Supplemental Information for NIH Developmental Studies Biospecimen Access Program FAQs for Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders - RFA-DA-23-014 Pre-Application Information Webinar for PAR-21-183, "Developing Digital Therapeutics for Substance Use Disorders FAQs Regarding Notice of Information: Establishment of a Standard THC Unit to be Used in Research (NOT-DA-21-049) Frequently Asked Questions about NOT-DA-21-041: Notice of Special Interest (NOSI) Announcing the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus RFA-DA-21-009: Pre-Application Webinar and FAQs- Interventions to Prevent Electronic Nicotine Delivery Systems (ENDS) Use Among Adolescents Step Up for Substance Use Disorders (SUD): A Drug Target Initiative for Scientists Engaged in Fundamental Research - RFA-DA-20-025 FAQs for Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1) FAQs for NOT-DA-19-003: HEAL Initiative: Request for Administrative Supplements to Existing Grants to Accelerate Research on Preventing Opioid Use Disorder in Older Adolescents and Young Adults (ages 16-30) Supplemental Information (FAQs) for NIDA Research E-cigarette - PAR-17-156 Supplemental Information (FAQs) for RFA-DA-17-014 and RFA-DA-17-023
According to the current listing, eligibility includes: Public/State controlled institutions of higher education, non-profits, small businesses, and other eligible institutional entities (individuals generally not eligible as primary applicants). Confirm the full requirements on the funder's own website before applying.
Limited Competition for the Adolescent Brain Cognitive Development -Extended (ABCD-E) Study-Research Project Sites (U01 Clinical Trial Not Allowed) is funded by National Institutes of Health (NIH) / National Institute on Drug Abuse (NIDA). Verify program details on the funder's own website before applying.
Start from the funder's website linked on this page and look for its grants or funding section — the link goes to the funder's site rather than a specific solicitation.
NIH Small Business Technology Transfer (STTR) Parent Grant (R41/R42 Clinical Trial Not Allowed) is sponsored by National Institutes of Health (NIH) / National Institute on Drug Abuse (NIDA). Similar to SBIR but requires collaboration with research institutions; funds AI, data analytics, and tech for SUD prevention, treatment engagement, recovery support, and overdose risk reduction. Matches the organization's AI-powered outreach and reengagement platform.
NIH Small Business Innovation Research (SBIR) Parent Grant (R43/R44 Clinical Trial Not Allowed) is sponsored by National Institutes of Health (NIH) / National Institute on Drug Abuse (NIDA). Supports small businesses developing innovative technologies, including AI/ML tools, for substance use disorders (SUD), behavioral health, patient engagement, relapse prevention, and related areas.
The HEAL Initiative's Studies to Enable Analgesic Discovery award (RFA-NS-25-023) puts federal money exactly where private capital won't go — the assay-building, screening, and hit-characterization stage of non-opioid pain therapeutics. It's a phased R61/R33, up to $350,000 in direct costs per year, with the next application deadline September 17, 2026. Here is how the two-phase structure works, who's eligible, and how to build a proposal that survives the R61-to-R33 milestone gate.
Read articleNICHD forecast RFA-HD-28-005 (CAPSTONE), RFA-HD-28-006 (Learning Disabilities Research Centers), and RFA-HD-28-001 (Discovery Gateway) on October 20, 2026. All three are due around October 1, 2027. Here is what the incumbents hold and how challengers should prepare.
Read articleNIH's RFI on administrative burden (NOT-OD-26-118) takes comments through December 8, 2026. It asks seven questions, lists eight reforms already made, and warns that responses may be posted unredacted. Here is what NIH is really asking for, what it can and cannot change alone, and how researchers and research offices should respond.
Read article